End-of-day quote
Korea S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
67,500
KRW
|
-2.17%
|
|
-2.32%
|
-2.32%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,004,168
|
747,641
|
604,345
|
523,481
|
597,946
|
587,290
|
-
|
-
|
Enterprise Value (EV)
2 |
968.7
|
745.6
|
713.4
|
615.5
|
597.9
|
714.3
|
692.3
|
600.3
|
P/E ratio
|
15.5
x
|
27
x
|
52.1
x
|
61
x
|
36.4
x
|
14.9
x
|
16.6
x
|
9.4
x
|
Yield
|
0.84%
|
1.13%
|
1.4%
|
1.15%
|
-
|
1.02%
|
1.11%
|
1.02%
|
Capitalization / Revenue
|
1.64
x
|
1.27
x
|
1.02
x
|
0.82
x
|
0.99
x
|
0.91
x
|
0.86
x
|
0.8
x
|
EV / Revenue
|
1.58
x
|
1.27
x
|
1.21
x
|
0.97
x
|
0.99
x
|
1.11
x
|
1.01
x
|
0.82
x
|
EV / EBITDA
|
12.6
x
|
13.8
x
|
20.2
x
|
12.1
x
|
10.1
x
|
10.1
x
|
10.2
x
|
7.06
x
|
EV / FCF
|
22.2
x
|
-74.2
x
|
-56.4
x
|
-64.5
x
|
-
|
11
x
|
14.7
x
|
7.5
x
|
FCF Yield
|
4.5%
|
-1.35%
|
-1.77%
|
-1.55%
|
-
|
9.1%
|
6.8%
|
13.3%
|
Price to Book
|
1.55
x
|
1.16
x
|
0.97
x
|
0.76
x
|
-
|
0.83
x
|
0.87
x
|
0.73
x
|
Nbr of stocks (in thousands)
|
8,779
|
8,779
|
8,782
|
8,782
|
8,653
|
8,701
|
-
|
-
|
Reference price
3 |
114,379
|
85,160
|
68,820
|
59,608
|
69,100
|
67,500
|
67,500
|
67,500
|
Announcement Date
|
2/12/20
|
2/3/21
|
2/8/22
|
2/13/23
|
3/18/24
|
-
|
-
|
-
|
1KRW in Million2KRW in Billions3KRW Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
612.2
|
586.6
|
590.1
|
635.8
|
605.2
|
646.1
|
686.8
|
730
|
EBITDA
1 |
77.05
|
54
|
35.34
|
51.02
|
59.05
|
71
|
67.78
|
85
|
EBIT
1 |
57
|
34.06
|
15.49
|
30.53
|
32.71
|
45.9
|
47.76
|
65
|
Operating Margin
|
9.31%
|
5.81%
|
2.63%
|
4.8%
|
5.4%
|
7.1%
|
6.95%
|
8.9%
|
Earnings before Tax (EBT)
1 |
83.1
|
33.84
|
11.34
|
13.55
|
21.39
|
51
|
47.32
|
81
|
Net income
1 |
65
|
27.65
|
11.97
|
9.02
|
17.3
|
39.8
|
36.46
|
63
|
Net margin
|
10.62%
|
4.71%
|
2.03%
|
1.42%
|
2.86%
|
6.16%
|
5.31%
|
8.63%
|
EPS
2 |
7,400
|
3,150
|
1,320
|
976.5
|
1,897
|
4,528
|
4,070
|
7,181
|
Free Cash Flow
3 |
43,572
|
-10,050
|
-12,657
|
-9,542
|
-
|
65,000
|
47,075
|
80,000
|
FCF margin
|
7,117.31%
|
-1,713.33%
|
-2,144.85%
|
-1,500.73%
|
-
|
10,060.62%
|
6,854.75%
|
10,958.9%
|
FCF Conversion (EBITDA)
|
56,550.61%
|
-
|
-
|
-
|
-
|
91,549.3%
|
69,449.23%
|
94,117.65%
|
FCF Conversion (Net income)
|
67,034.1%
|
-
|
-
|
-
|
-
|
163,316.58%
|
129,114.1%
|
126,984.13%
|
Dividend per Share
2 |
961.2
|
961.2
|
961.2
|
686.3
|
-
|
687.0
|
752.0
|
687.0
|
Announcement Date
|
2/12/20
|
2/3/21
|
2/8/22
|
2/13/23
|
3/18/24
|
-
|
-
|
-
|
1KRW in Billions2KRW3KRW in Million Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
151.9
|
149.9
|
153.5
|
160.2
|
158.3
|
163.8
|
135.1
|
154.1
|
150.2
|
165.7
|
140.3
|
165.1
|
170.1
|
177.2
|
157.6
|
EBITDA
1 |
-
|
-
|
-
|
-
|
15.45
|
9.347
|
-
|
9.854
|
19.57
|
12.58
|
13.6
|
16.4
|
17.6
|
13.6
|
-
|
EBIT
1 |
11.64
|
-4.861
|
7.887
|
4.317
|
14.17
|
4.149
|
6.682
|
8.753
|
13.08
|
4.197
|
7
|
12.1
|
14.9
|
11.7
|
8.9
|
Operating Margin
|
7.66%
|
-3.24%
|
5.14%
|
2.69%
|
8.96%
|
2.53%
|
4.94%
|
5.68%
|
8.7%
|
2.53%
|
4.99%
|
7.33%
|
8.76%
|
6.6%
|
5.65%
|
Earnings before Tax (EBT)
1 |
12.52
|
-8.252
|
7.247
|
4.503
|
22.17
|
-20.38
|
11.72
|
6.178
|
14.76
|
-11.26
|
12.2
|
17.5
|
20.4
|
0.9
|
14.9
|
Net income
1 |
11.33
|
-5.755
|
2.291
|
3.831
|
24.04
|
-17.55
|
9.132
|
4.813
|
11.5
|
-8.143
|
9.5
|
13.6
|
15.9
|
0.7
|
11.6
|
Net margin
|
7.46%
|
-3.84%
|
1.49%
|
2.39%
|
15.19%
|
-10.71%
|
6.76%
|
3.12%
|
7.65%
|
-4.91%
|
6.77%
|
8.24%
|
9.35%
|
0.4%
|
7.36%
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/2/21
|
2/8/22
|
4/27/22
|
7/27/22
|
10/26/22
|
2/13/23
|
4/27/23
|
7/27/23
|
10/31/23
|
3/18/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
109
|
92
|
-
|
127
|
105
|
13
|
Net Cash position
1 |
35.5
|
2
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
3.087
x
|
1.803
x
|
-
|
1.789
x
|
1.55
x
|
0.1529
x
|
Free Cash Flow
2 |
43,572
|
-10,050
|
-12,657
|
-9,542
|
-
|
65,000
|
47,075
|
80,000
|
ROE (net income / shareholders' equity)
|
10.5%
|
2.5%
|
1.83%
|
1.35%
|
-
|
5.8%
|
5.08%
|
8.2%
|
ROA (Net income/ Total Assets)
|
6.6%
|
1.62%
|
1.14%
|
0.8%
|
-
|
3.1%
|
3.1%
|
4.4%
|
Assets
1 |
985.4
|
1,707
|
1,050
|
1,125
|
-
|
1,284
|
1,176
|
1,432
|
Book Value Per Share
3 |
73,987
|
73,631
|
71,135
|
78,078
|
-
|
81,042
|
77,456
|
92,837
|
Cash Flow per Share
3 |
6,412
|
3,071
|
5,221
|
3,740
|
-
|
6,157
|
6,463
|
-
|
Capex
1 |
12.7
|
37
|
61.1
|
44.1
|
-
|
9.5
|
9.94
|
-
|
Capex / Sales
|
2.08%
|
6.31%
|
10.35%
|
6.93%
|
-
|
1.47%
|
1.45%
|
-
|
Announcement Date
|
2/12/20
|
2/3/21
|
2/8/22
|
2/13/23
|
3/18/24
|
-
|
-
|
-
|
1KRW in Billions2KRW in Million3KRW |
1st Jan change
|
Capi.
|
---|
| -2.32% | 427M | | +5.31% | 70.44B | | +10.97% | 8.94B | | -16.83% | 4.75B | | +43.48% | 4.5B | | +3.20% | 3.85B | | +18.82% | 2.38B | | -21.36% | 2.34B | | -29.67% | 2.2B | | +8.38% | 1.96B |
Specialty & Advanced Pharmaceuticals
|